B
CBAY

Bailard’s Cymabay Therapeutics CBAY Stock Holding History

Bailard’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,700
Closed -$46K – 820
2021
Q4 		$46K Buy
+13,700
New +$52K ﹤0.01% 712
2019
Q4 		– Sell
-308,700
Closed -$1.58M – 620
2019
Q3 		$1.58M Hold
308,700
– – 0.1% 177
2019
Q2 		$2.21M Buy
308,700
+93,600
+44% +$1.06M 0.14% 148
2019
Q1 		$2.86M Buy
215,100
+90,100
+72% +$958K 0.18% 120
2018
Q4 		$984K Buy
+125,000
New +$1.19M 0.07% 218

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return